InvestorsHub Logo
Followers 18
Posts 850
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Wednesday, 01/06/2016 1:03:44 PM

Wednesday, January 06, 2016 1:03:44 PM

Post# of 1313
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it received a 510(k) clearance (K152954) from the U.S. Food and Drug Administration (FDA) for an upgraded version of Quell, the company’s over-the-counter, 100% drug free chronic pain relief wearable. Under this 510(k), the Quell device can be controlled directly via the Quell Relief smartphone app. This provides an unprecedented level of convenience and comfort when using Quell to treat chronic pain.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NURO News